Side effects of ibrutinib

Ibrutinib (Ibrutinib) is a drug used to treat certain types of leukemia and lymphoma. Although it has significant efficacy in treating malignant diseases, it may also cause a series of side effects. These side effects may vary among individuals, but it is important for patients taking ibrutinib to understand and monitor them. The side effects of ibrutinib will be discussed in detail below:

1. Tendency to bleeding and congestion:

Ibrutinib may cause bleeding and congestion, including epistaxis, gum bleeding, subcutaneous congestion, etc. This is because ibrutinib affects the function of platelets, which are responsible for stopping bleeding. Patients should check their platelet counts regularly and avoid strenuous exercise and blood-thinning medications.

2. High blood pressure:

Ibrutinib can cause hypertension, which may require pharmacological intervention to control. Patients should measure their blood pressure regularly during medication and follow their doctor's treatment recommendations.

3. Abnormal liver function:

Some patients may experience liver function abnormalities while taking ibrutinib, manifesting as jaundice, elevated liver enzymes and other symptoms. Doctors usually check liver function regularly to make sure there are no serious problems.

4. Arrhythmia:

Ibrutinib can sometimes cause arrhythmias, including palpitations and irregular heartbeats. Patients should notify their doctor immediately, who may order an electrocardiogram if these symptoms occur.

5. Fatigue:

Fatigue is a common discomfort caused by ibrutinib and may affect patients' daily life. Rest, moderate exercise, and good nutrition can help relieve fatigue.

6. Nausea and diarrhea:

Ibrutinib can sometimes cause nausea and diarrhea, often early in treatment. Patients can reduce these discomforts by dividing their meals, drinking more fluids, and consulting their doctor for medications.

7. Skin reaction:

Ibrutinib may cause skin reactions such as itching, rash, and dry skin. Keeping your skin clean, using gentle skin care products, and avoiding intense sun exposure can help reduce these symptoms.

8. Headache and dizziness:

Some patients may experience headache and dizziness while taking ibrutinib. These symptoms are usually temporary, but if they are severe or last longer, your doctor should be informed.

9. Difficulty breathing:

Ibrutinib can sometimes cause difficulty breathing, and patients should seek medical attention immediately if this occurs. This can be a serious side effect and needs to be dealt with promptly.

10. Increased risk of infection:

Ibrutinib may reduce the function of the immune system, making patients more susceptible to infection. Patients should avoid contact with known infected people and receive regular vaccinations recommended by their doctor.

11. Skeleton related issues:

Ibrutinib may cause an increased risk of osteoporosis and fractures. Patients may need to monitor bone density regularly and consider calcium and vitamin DD supplementation.

12. Relief treatment:

In some cases, doctors may need to pause or reduce the dose of ibrutinib to reduce side effects or manage other medical problems.

In conclusion, ibrutinib is a powerful therapeutic tool for certain types of leukemia and lymphoma. However, patients and physicians should work closely together to monitor and manage possible side effects to ensure optimal treatment effectiveness and quality of life. Patients should always stay in contact with their medical team while taking the medication and promptly report any symptoms of discomfort. Only with close monitoring and appropriate support can ibrutinib reach its full therapeutic potential.

Ibrutinib is currently on the market in China and is included in medical insurance. The domestic price ranges from 10,000 to 20,000. Due to different medical insurance policies in different places, the price is also different. For specific reimbursement information, please consult the local hospital pharmacy or medical insurance bureau. The cheaper types of ibrutinib abroad are generic drugs, mainly Indian generic drugs, Bangladeshi generic drugs and Laos generic drugs, with prices ranging from a few hundred to several thousand yuan. And the ingredients of generic ibrutinib drugs are basically the same as those of domestic ibrutinib drugs.